title: [Acute coronary syndrome in patients with type 2 diabetes mellitus].
abstract: According to evidence obtained from large epidemiological studies, an incidence rate of acute coronary syndrome (ACS) in diabetics is 2-3 times higher than in general population. Relevant invalidity and mortality is much higher than in patients free of diabetes. In type 2 diabetes mellitus a high risk of an unfavourable course and outcome of myocardial infarction was registered both within 30 postinfarction days and 1-3 years of follow-up. Poor prognosis persists despite adequate and early treatment. The results of the attempts to correct MI prognosis in diabetics by means of carbohydrate metabolism correction (multicenter trials DIGAMI-1, DIGAMI-2) are reviewed.
authors.forename: A S
authors.initials: AS
authors.lastname: Ametov
authors.forename: O P
authors.initials: OP
authors.lastname: P'ianykh
authors.forename: E N
authors.initials: EN
authors.lastname: Aslandziia
mesh_terms: D054058:Acute Coronary Syndrome / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism / Q000401:mortality; D050260:Carbohydrate Metabolism / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism / Q000401:mortality; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007333:Insulin Resistance; D009026:Mortality / Q000639:trends; D015337:Multicenter Studies as Topic; D011379:Prognosis
chemical_list: D007004:Hypoglycemic Agents